In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models—A report from the Pediatric Preclinical Testing Consortium
2019 ◽
2019 ◽
2004 ◽
Vol 10
(17)
◽
pp. 5940-5948
◽
Keyword(s):
2014 ◽
Vol 207
(9)
◽
pp. 403-411
◽
Keyword(s):
2005 ◽
Vol 25
(1_suppl)
◽
pp. S598-S598
◽
2005 ◽
Vol 25
(1_suppl)
◽
pp. S597-S597